| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.019 | 0.9 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.002 | 0.9 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |